큐리오시스

494120· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩8,160-1.21%

2026-09-18

Financials

Valuation Metrics

큐리오시스's Market Cap is ₩1245B. Ranked #1143 of 2,421 in KR market (top 47%), #607 of 1,640 on KOSDAQ (top 37%), #132 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 57%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	124.52B KRW	KR#1,143/2,421 Sec#132/231
Revenue	8.38B KRW	KR#2,302/2,421 Sec#180/231
Net Income	-7.89B KRW	KR—/2,421 Sec—/231
Total Assets	31.94B KRW	KR#2,326/2,421 Sec#220/231
Net Assets	24.72B KRW	KR#2,232/2,421 Sec#206/231
Value
P/B	5.04x	KR#2,244/2,421 Sec#190/231
P/S	14.87x	KR#2,315/2,421 Sec#174/231
FCF Yield	-7.70%	KR—/2,421 Sec—/231
Profitability
ROE	-31.91%	KR#2,199/2,421 Sec#181/231
ROA	-24.69%	KR#2,278/2,421 Sec#188/231
Op. Margin	-93.67%	KR#2,297/2,421 Sec#171/231
Financial Health
Debt Ratio	29.21%	KR#565/2,421 Sec#64/231
Total Debt	2.77B KRW	KR#1,876/2,421 Sec#180/231
FCF	-9.58B KRW	KR#1,697/2,421 Sec#145/231
Cash	17.04B KRW	KR#1,349/2,421 Sec#106/231
Current Ratio	6.00x	KR#217/2,421 Sec#43/231
Performance
1M Return	-21.76%	KR#2,313/2,421 Sec#212/231
From 52W High	-83.08%	KR#2,366/2,421 Sec#224/231
1Y MDD	-82.33%	KR#2,332/2,421 Sec#220/231
Trading
Volume	76,153 shares	KR#922/2,421 Sec#96/231
Trading Value	630.8M KRW	KR#862/2,421 Sec#87/231
Foreign Own.	5.96%	KR#735/2,421 Sec#66/231
Per Share
EPS	-517 KRW	KR—/2,421 Sec—/231
BPS	1,620 KRW	KR#2,158/2,421 Sec#182/231